Revolutionising the healthcare industry, Sri Lanka’s leading private sector bank, HNB PLC, partnered with a trusted supplier of globally recognised diagnostic brands, Japlan Diagnostics Pvt. Ltd., to offer state-of-the-art diagnostic tools and services to institutions across the island.
The strategic collaboration offers the medical industry a range of advanced diagnostic tools, including the TOSOH AIA 360-Immuno assay analyzers, TOSOH HLC 723 GX-HbA1c analyzers, HORIBA PENTRA C400 – Bio chemistry analyzers, JOKOH IONEX – Electrolyte analyzers & NANOENTEK – point of care products with convenient payment options.
Assistant General Manager – Personal Financial Services, Kanchana Karunagama, Head of Leasing Susith Perera and Japlan Diagnostics Managing Director Prasad Wijesekera, Executive Director Amila Gallage, Directors Dilshan Abeywardena and Kanishka Weerasinghe graced the special ceremony held to commemorate the partnership.
“We are thrilled to collaborate with Japlan Diagnostics in this transformative partnership, which provides access to cutting-edge diagnostics tools to elevate the medical industry in Sri Lanka. Our shared commitment to delivering excellence in healthcare is reflected in our concerted efforts to grant access to state-of-the-art tools to medical professionals, fostering precision in diagnostics and paving the way for advancements in personalized medication. We are dedicated to supporting the medical industry, and through this collaboration, we aim to empower institutions with the tools necessary for delivering exceptional and personalised patient care,” HNB Assistant Geneal Manager – Personal Financial Services, Kanchana Karunagama said.
HNB will offer customers using the leasing facility, exclusive rates and repayment plans suited to their budget. Moreover, the bank will provide exclusive perks through the complimentary Prestige Prime credit card, including the waiver of the first-year annual fee.
“We are excited about the possibilities that our partnership with HNB opens up for the medical industry in Sri Lanka. By joining forces with HNB, we aim to provide the medical sector access to state-of-the-art diagnostic equipment, empowering healthcare professionals to deliver the best possible diagnostic services. This collaboration aligns with our commitment to leveraging cutting-edge technology to elevate the country’s medical diagnostics standards. Together with HNB, we look forward to contributing to a healthier and more advanced healthcare landscape,” Japlan Diagnostics Director Mr Kanishka Weerasinghe said.
Japlan Diagnostics will offer customers using the facility exclusive discounts and an additional layer of security during the promotional period.
Japlan’s Diagnostics represents renowned multinational brands that deliver unparalleled services in medical, surgical and diagnostics services and related services. At the core of Japlan’s diagnostic business are world-renowned brands such as TOSOH and HORIBA and JOKOH from Japan and NanoEntek from south Korea. These brands are the world’s leading suppliers of in-vitro diagnostics (IVDs), providing diagnostic instruments and reagents that enable healthcare professionals to detect diseases, select appropriate treatments, and monitor patients’ responses to care.
With 254 customer centres and 800+ Self Service Machines (SSMs) nationwide, HNB is one of Sri Lanka’s largest, most technologically innovative private banks. Consolidating its legacy in sustainability, good governance and corporate excellence, HNB was crowned the Best Corporate Citizen for 2022 at the Ceylon Chamber of Commerce Best Corporate Citizen Awards.
Additionally, HNB was ranked among the World’s Top 1,000 Banks list compiled by the prestigious UK-based Banker Magazine for the sixth consecutive year in 2022, in addition to being crowned the Best Retail Bank in Sri Lanka for the 13th occasion at the prestigious International Excellence in Retail Financial Services Awards 2023 hosted by the Asian Banker Magazine.